# Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

> **NCT00271479** · PHASE4 · COMPLETED · sponsor: **Epicentre** · enrollment: 720 (—)

## Conditions studied

- Infections, Meningococcal
- Meningitis, Meningococcic

## Interventions

- **BIOLOGICAL:** A, C, Y, W135 meningococcal polysaccharide vaccine

## Key facts

- **NCT ID:** NCT00271479
- **Lead sponsor:** Epicentre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 720 (—)
- **Last updated:** 2006-12-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271479, "Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00271479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*